Medical Treatment in Elderly Patients with Non-Small Cell Lung Cancer.

about

Anaplastic lymphoma kinase inhibitors in elderly patients with advanced non-small cell lung cancer.

P2860

Q38872183-63C0BADE-AE5C-48F9-9986-1D162A95AFC4

P2860

Medical Treatment in Elderly Patients with Non-Small Cell Lung Cancer.

Item

http://www.wikidata.org/entity/Q38760512

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Medical Treatment in Elderly Patients with Non-Small Cell Lung Cancer.

@en

type

Item

label

Medical Treatment in Elderly Patients with Non-Small Cell Lung Cancer.

@en

prefLabel

Medical Treatment in Elderly Patients with Non-Small Cell Lung Cancer.

@en

P1476

Medical Treatment in Elderly Patients with Non-Small Cell Lung Cancer.

@en

P2093

Haiying Cheng

http://www.w3.org/2001/XMLSchema#string

Janaki Sharma

http://www.w3.org/2001/XMLSchema#string

Kamila Bakirhan

http://www.w3.org/2001/XMLSchema#string

Roman Perez-Soler

http://www.w3.org/2001/XMLSchema#string

P2860

The ELVIS trial: a phase III study of single-agent vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer. Elderly Lung Cancer Vinorelbine Italian Study.

A randomized phase II trial of pemetrexed/gemcitabine/bevacizumab or pemetrexed/carboplatin/bevacizumab in the first-line treatment of elderly patients with advanced non-small cell lung cancer.

Comparison of the efficacy and safety of single-agent and doublet chemotherapy in advanced non-small cell lung cancer in the elderly: a meta-analysis.

Weekly nab-paclitaxel in combination with carboplatin versus solvent-based paclitaxel plus carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer: final results of a phase III trial.

Pemetrexed and carboplatin, an active option in first-line treatment of elderly patients with advanced non-small cell lung cancer (NSCLC): a phase II trial.

Phase II study of pemetrexed as first-line treatment in elderly (≥75) non-squamous non-small-cell lung cancer: Kyoto Thoracic Oncology Research Group Trial 0901.

A phase II study of pemetrexed in chemotherapy-naive elderly patients aged ≥ 75 years with advanced non-squamous non-small-cell lung cancer (HANSHIN Oncology Group 003).

NCCTG N0821 (Alliance): a phase II first-line study of pemetrexed, carboplatin, and bevacizumab in elderly patients with advanced nonsquamous non-small-cell lung cancer with good performance status

Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data

Cancer screening in elderly patients: a framework for individualized decision making.

P2888

s11864-016-0388-2

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11864-016-0388-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1047743371

http://www.w3.org/2001/XMLSchema#string

P698

26942588

http://www.w3.org/2001/XMLSchema#string

Medical Treatment in Elderly Patients with Non-Small Cell Lung Cancer.

about

P2860

P2860

Medical Treatment in Elderly Patients with Non-Small Cell Lung Cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698